Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 7, 2011, Pages 711-718

  Avnet, Sofia ^a   Pallotta, Rosanna ^b   Perut, Francesca ^a   Baldini, Nicola ^a   Pittis, Maria Gabriela ^c   Saponari, Anita ^b   Lucarelli, Enrico ^a   Dozza, Barbara ^a   Greggi, Tiziana ^a   Maraldi, Nadir M ^a   Capanni, Cristina ^d   Mattioli, Elisabetta ^d   Columbaro, Marta ^a   Lattanzi, Giovanna ^d  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

^d CNR   (Italy)

Author keywords

Lamin A C; Mandibuloacral dysplasia; Osteoblast; Osteoclast; Osteoprotegerin; TGFbeta 2

Indexed keywords

DEXAMETHASONE; OSTEOPROTEGERIN; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BONE MATRIX; BONE MINERAL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CERVICAL SPINE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; JAW MALFORMATION; MANDIBULOACRAL DYSPLASIA TYPE A; MONOCYTE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

ACRO-OSTEOLYSIS; ALKALINE PHOSPHATASE; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; MICROSCOPY, ELECTRON; OSTEOBLASTS; OSTEOCLASTS;

EID: 79955641987     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.03.006     Document Type: Article

References (34)

1. Hassan M.Q., Gordon J.A., Beloti M.M., Croce C.M., Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19879-19884.
2. Wright H.L., McCarthy H.S., Middleton J., Marshall M.J. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr. Rev. Musculoskelet. Med. 2009, 2:56-64.
3. Costa-Rodrigues J., Teixeira C.A., Sampaio P., Fernandes M.H. Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media. J. Cell. Biochem. 2010, 109:205-216.
4. Akter R., Rivas D., Geneau G., Drissi H., Duque G. Effect of Lamin A/C Knockdown on Osteoblast Differentiation and Function. J. Bone Miner. Res. 2008.
5. Maraldi N.M., Lattanzi G., Cenni V., Bavelloni A., Marmiroli S., Manzoli F.A. Laminopathies and A-type lamin-associated signalling pathways. Adv. Enzyme Regul. 2010, 50:248-261.
6. Marmiroli S., Bertacchini J., Beretti F., Cenni V., Guida M., De Pol A., Maraldi N.M., Lattanzi G. A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward. J. Cell. Physiol. 2009, 220:553-561.
7. Novelli G., Muchir A., Sangiuolo F., Helbling-Leclerc A., D'Apice M.R., Massart C., Capon F., Sbraccia P., Federici M., Lauro R., Tudisco C., Pallotta R., Scarano G., Dallapiccola B., Merlini L., Bonne G. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 2002, 71:426-431.
8. Rauner M., Sipos W., Goettsch C., Wutzl A., Foisner R., Pietschmann P., Hofbauer L.C. Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis. J. Bone Miner. Res. 2009, 24:78-86.
9. Akter R., Rivas D., Geneau G., Drissi H., Duque G. Effect of lamin A/C knockdown on osteoblast differentiation and function. J. Bone Miner. Res. 2009, 24:283-293.
10. Rivas D., Li W., Akter R., Henderson J.E., Duque G. Accelerated features of age-related bone loss in zmpste24 metalloproteinase-deficient mice. J. Gerontol. A, Biol. Sci. Med. Sci. 2009, 64:1015-1024.
11. Zini N., Avnet S., Ghisu S., Maraldi N.M., Squarzoni S., Baldini N., Lattanzi G. Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts. J. Cell. Biochem. 2008, 105:34-40.
12. Amato I., Ciapetti G., Pagani S., Marletta G., Satriano C., Baldini N., Granchi D. Expression of cell adhesion receptors in human osteoblasts cultured on biofunctionalized poly-(epsilon-caprolactone) surfaces. Biomaterials 2007, 28:3668-3678.
13. Granchi D., Baglio S.R., Amato I., Giunti A., Baldini N. Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells. Int. J. Cancer 2008, 123:1526-1535.
14. Granchi D., Amato I., Battistelli L., Avnet S., Capaccioli S., Papucci L., Donnini M., Pellacani A., Brandi M.L., Giunti A., Baldini N. In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int. J. Cancer 2004, 111:829-838.
15. Cenni E., Ciapetti G., Granchi D., Fotia C., Perut F., Giunti A., Baldini N. Endothelial cells incubated with platelet-rich plasma express PDGF-B and ICAM-1 and induce bone marrow stromal cell migration. J. Orthop. Res. 2009, 27:1493-1498.
16. Mattioli E., Columbaro M., Capanni C., Santi S., Maraldi N.M., D'Apice M.R., Novelli G., Riccio M., Squarzoni S., Foisner R., Lattanzi G. Drugs affecting prelamin A processing: Effects on heterochromatin organization. Exp. Cell Res. 2008, 314:453-462.
17. Pallotta R., Morgese G. Mandibuloacral dysplasia: a rare progeroid syndrome. Two brothers confirm autosomal recessive inheritance. Clin. Genet. 1984, 26:133-138.
18. Kosho T., Takahashi J., Momose T., Nakamura A., Sakurai A., Wada T., Yoshida K., Wakui K., Suzuki T., Kasuga K., Nishimura G., Kato H., Fukushima Y. Mandibuloacral dysplasia and a novel LMNA mutation in a woman with severe progressive skeletal changes. Am. J. Med. Genet. A 2007, 143A:2598-2603.
19. Capanni C., Del Coco R., Mattioli E., Camozzi D., Columbaro M., Schena E., Merlini L., Squarzoni S., Maraldi N.M., Lattanzi G. Emerin-prelamin A interplay in human fibroblasts. Biol. Cell 2009, 101:541-554.
20. Itonaga I., Sabokbar A., Sun S.G., Kudo O., Danks L., Ferguson D., Fujikawa Y., Athanasou N.A. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 2004, 34:57-64.
21. Varela I., Pereira S., Ugalde A.P., Navarro C.L., Suarez M.F., Cau P., Cadinanos J., Osorio F.G., Foray N., Cobo J., de Carlos F., Levy N., Freije J.M., Lopez-Otin C. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 2008, 14:767-772.
22. Yang S.H., Andres D.A., Spielmann H.P., Young S.G., Fong L.G. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J. Clin. Invest. 2008, 118:3291-3300.
23. Capanni C., Mattioli E., Columbaro M., Lucarelli E., Parnaik V.K., Novelli G., Wehnert M., Cenni V., Maraldi N.M., Squarzoni S., Lattanzi G. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum. Mol. Genet. 2005, 14:1489-1502.
24. Cunningham V.J., D'Apice M.R., Licata N., Novelli G., Cundy T. Skeletal phenotype of mandibuloacral dysplasia associated with mutations in ZMPSTE24. Bone 2010, 47:591-597.
25. Duque G., Rivas D. Age-related changes in lamin A/C expression in the osteoarticular system: laminopathies as a potential new aging mechanism. Mech. Ageing Dev. 2006, 127:378-383.
26. Hemingway F., Taylor R., Knowles H.J., Athanasou N.A. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011.
27. Wu X.Y., Wu X.P., Luo X.H., Xie H., Zhang H., Peng Y.Q., Yuan L.Q., Jiang Y.B., Liao E.Y. The relationship between the levels of gonadotropic hormones and OPG, Leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. Clin. Chim. Acta 2010.
28. Garg A., Subramanyam L., Agarwal A.K., Simha V., Levine B., D'Apice M.R., Novelli G., Crow Y. Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J. Clin. Endocrinol. Metab. 2009, 94:4971-4983.
29. Prokocimer M., Davidovich M., Nissim-Rafinia M., Wiesel-Motiuk N., Bar D., Barkan R., Meshorer E., Gruenbaum Y. Nuclear lamins: key regulators of nuclear structure and activities. J. Cell. Mol. Med. 2009.
30. Konde E., Bourgeois B., Tellier-Lebegue C., Wu W., Perez J., Caputo S., Attanda W., Gasparini S., Charbonnier J.B., Gilquin B., Worman H.J., Zinn-Justin S. Structural Analysis of the Smad2-MAN1 Interaction That Regulates Transforming Growth Factor-beta Signaling at the Inner Nuclear Membrane. Biochemistry 2010, 49:8020-8032.
31. Muchir A., Shan J., Bonne G., Lehnart S.E., Worman H.J. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum. Mol. Genet. 2009, 18:241-247.
32. Fox S.W., Evans K.E., Lovibond A.C. Transforming growth factor-beta enables NFATc1 expression during osteoclastogenesis. Biochem. Biophys. Res. Commun. 2008, 366:123-128.
33. Ashley D.T., O'Sullivan E.P., Davenport C., Devlin N., Crowley R.K., McCaffrey N., Moyna N.M., Smith D., O'Gorman D.J. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. Metabolism 2010.
34. O'Sullivan E.P., Ashley D.T., Davenport C., Devlin N., Crowley R., Agha A., Thompson C.J., O'Gorman D., Smith D. Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes. Diabetes Metab. Res. Rev. 2011, 26:496-502.